| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 5.57M | 4.67M | 918.55K | 193.34K | 0.00 | 0.00 |
| Gross Profit | 3.30M | 2.78M | 299.31K | 83.94K | 0.00 | 0.00 |
| EBITDA | -5.48M | -1.89M | -4.25M | -5.30M | -3.63M | -11.67K |
| Net Income | -3.79M | -3.02M | -4.56M | -5.38M | -3.45M | -13.47K |
Balance Sheet | ||||||
| Total Assets | 42.65M | 19.41M | 3.84M | 7.16M | 5.93M | 154.19K |
| Cash, Cash Equivalents and Short-Term Investments | 38.15M | 15.74M | 1.29M | 5.07M | 3.74M | 38.30K |
| Total Debt | 1.18M | 941.00K | 1.07M | 458.66K | 615.69K | 0.00 |
| Total Liabilities | 1.76M | 1.51M | 1.57M | 1.05M | 831.14K | 147.91K |
| Stockholders Equity | 40.89M | 17.90M | 2.28M | 6.11M | 5.10M | 6.28K |
Cash Flow | ||||||
| Free Cash Flow | -1.17M | -1.31M | -3.78M | -4.31M | -3.21M | -107.61K |
| Operating Cash Flow | -852.80K | -1.15M | -3.45M | -3.64M | -2.25M | -1.38K |
| Investing Cash Flow | -403.62K | -161.00K | -321.84K | -672.54K | -955.67K | -106.23K |
| Financing Cash Flow | 36.05M | 15.76M | -4.00K | 5.64M | 161.93K | 145.70K |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
68 Neutral | $315.82M | 22.30 | 22.20% | 6.13% | -9.48% | -14.28% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
61 Neutral | $709.60M | -27.77 | -12.00% | ― | -4.54% | -119.39% | |
55 Neutral | $265.55M | -54.47 | -17.77% | ― | 307.44% | 14.77% | |
54 Neutral | $210.28M | -375.20 | -0.91% | ― | -0.41% | -134.49% | |
51 Neutral | $149.45M | -4.84 | -23.56% | ― | 7.53% | -15.00% | |
41 Neutral | $70.97M | -3.35 | -116.86% | ― | -94.26% | 3.20% |
Aeluma, Inc. announced its FY2025 results on September 9, 2025, highlighting significant financial and operational achievements, including a Nasdaq IPO and capital raises totaling $39.2 million. The company reported a revenue increase to $4.7 million from $0.9 million in FY24, secured six R&D contracts, and engaged with 20 active customers. Aeluma also unveiled a scalable manufacturing process applicable to quantum computing and communication systems, positioning itself for growth in multiple high-growth markets.
On June 23, 2025, Aeluma, Inc. director Mr. Steven DenBaars adopted a Rule 10b5-1 trading plan to sell up to 130,000 shares of the company’s common stock. However, on September 16, 2025, Mr. DenBaars terminated the plan, resulting in no sales being made under this arrangement.
On September 17, 2025, Aeluma, Inc. entered into an underwriting agreement with Craig-Hallum Capital Group LLC for a public offering of 1,700,000 shares of its common stock at $13.00 per share, which closed on September 19, 2025. The company raised approximately $23.4 million from the offering, which will be used to expand business development efforts, advance manufacturing processes, and for general business purposes, thereby potentially strengthening its market position and operational capabilities.